These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Innate immunity to pneumococcal infection of the central nervous system depends on toll-like receptor (TLR) 2 and TLR4. Klein M; Obermaier B; Angele B; Pfister HW; Wagner H; Koedel U; Kirschning CJ J Infect Dis; 2008 Oct; 198(7):1028-36. PubMed ID: 18700834 [TBL] [Abstract][Full Text] [Related]
12. The critical DNA flanking sequences of a CpG oligodeoxynucleotide, but not the 6 base CpG motif, can be replaced with RNA without quantitative or qualitative changes in Toll-like receptor 9-mediated activity. Sen G; Flora M; Chattopadhyay G; Klinman DM; Lees A; Mond JJ; Snapper CM Cell Immunol; 2004; 232(1-2):64-74. PubMed ID: 15922717 [TBL] [Abstract][Full Text] [Related]
13. Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of toll-like receptor 9. Knuefermann P; Schwederski M; Velten M; Krings P; Ehrentraut H; Rüdiger M; Boehm O; Fink K; Dreiner U; Grohé C; Hoeft A; Baumgarten G; Koch A; Zacharowski K; Meyer R Cardiovasc Res; 2008 Apr; 78(1):26-35. PubMed ID: 18194990 [TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor and RIG-I-like receptor signaling. Kawai T; Akira S Ann N Y Acad Sci; 2008 Nov; 1143():1-20. PubMed ID: 19076341 [TBL] [Abstract][Full Text] [Related]
16. The role of Toll-like receptors 3 and 9 in the development of autoimmune diabetes in NOD mice. Wong FS; Hu C; Zhang L; Du W; Alexopoulou L; Flavell RA; Wen L Ann N Y Acad Sci; 2008 Dec; 1150():146-8. PubMed ID: 19120284 [TBL] [Abstract][Full Text] [Related]
17. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses. Merlo A; Calcaterra C; Mènard S; Balsari A J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660 [TBL] [Abstract][Full Text] [Related]
18. Identification of an N-terminal recognition site in TLR9 that contributes to CpG-DNA-mediated receptor activation. Peter ME; Kubarenko AV; Weber AN; Dalpke AH J Immunol; 2009 Jun; 182(12):7690-7. PubMed ID: 19494293 [TBL] [Abstract][Full Text] [Related]
19. Recent advances in the development of immunostimulatory oligonucleotides. Uhlmann E; Vollmer J Curr Opin Drug Discov Devel; 2003 Mar; 6(2):204-17. PubMed ID: 12669456 [TBL] [Abstract][Full Text] [Related]
20. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways. Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]